Ceterix CEO John McCutcheon Is Writing a Different Ending with New Tech That Can Save the Meniscus
In 2010, John McCutcheon joined Ceterix, a start-up with big goals and a surer FDA path than his previous company. McCutcheon recounts the FDA's battering of that company, Emphasys, and explains how his current company is rolling today.
Ceterix CEO John McCutcheon Is Writing a Different Ending with New Tech That Can Save the Meniscus
In 2010, John McCutcheon joined Ceterix, a start-up with big goals and a surer FDA path than his previous company. McCutcheon recounts the FDA's battering of that company, Emphasys, and explains how his current company is rolling today.